Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Buchegger

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
EJNMMI Research|January 5, 2012
Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphomaFranz Buchegger, Oliver W Press
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 29, 2004
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targetingLeila Nobs, Franz Buchegger, Robert Gurny, et al.
Bioconjugate Chemistry|January 19, 2006
Biodegradable nanoparticles for direct or two-step tumor immunotargetingLeila Nobs, Franz Buchegger, Robert Gurny, et al.
Journal of Pharmaceutical Sciences|July 6, 2004
Current methods for attaching targeting ligands to liposomes and nanoparticlesLeila Nobs, Franz Buchegger, Robert Gurny, et al.
International Journal of Pharmaceutics|January 16, 2003
Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methodsLeila Nobs, Franz Buchegger, Robert Gurny, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 28, 2007
Effect of an immunonutrient mix on human colorectal adenocarcinoma cell growth and viabilityYves M Dupertuis, Gaëlle Benais-Pont, Franz Buchegger, et al.
Revue Medicale De La Suisse Romande|September 6, 2002
[Nutrition and tumoral growth]Yves M Dupertuis, Comasia A Raguso, Franz Buchegger, et al.
Current Vascular Pharmacology|November 6, 2013
PET Molecular Imaging of Hypoxia in Ischemic Stroke: An UpdateAylin Baskin, Franz Buchegger, Yann Seimbille, et al.
The Oncologist|July 1, 2008
Radiolabeled and native antibodies and the prospect of cure of follicular lymphomaFranz Buchegger, Oliver W Press, Angelika Bischof Delaloye, et al.
Bulletin Du Cancer|September 20, 2007
[Radioimmunotherapy of follicular lymphoma: a step towards cure?]Nicolas Ketterer, Angelika Bischof Delaloye, Claudine Helg, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
EJNMMI Research|January 5, 2012
Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphomaFranz Buchegger, Oliver W Press
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 29, 2004
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targetingLeila Nobs, Franz Buchegger, Robert Gurny, et al.
Bioconjugate Chemistry|January 19, 2006
Biodegradable nanoparticles for direct or two-step tumor immunotargetingLeila Nobs, Franz Buchegger, Robert Gurny, et al.
Journal of Pharmaceutical Sciences|July 6, 2004
Current methods for attaching targeting ligands to liposomes and nanoparticlesLeila Nobs, Franz Buchegger, Robert Gurny, et al.
International Journal of Pharmaceutics|January 16, 2003
Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methodsLeila Nobs, Franz Buchegger, Robert Gurny, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 28, 2007
Effect of an immunonutrient mix on human colorectal adenocarcinoma cell growth and viabilityYves M Dupertuis, Gaëlle Benais-Pont, Franz Buchegger, et al.
Revue Medicale De La Suisse Romande|September 6, 2002
[Nutrition and tumoral growth]Yves M Dupertuis, Comasia A Raguso, Franz Buchegger, et al.
Current Vascular Pharmacology|November 6, 2013
PET Molecular Imaging of Hypoxia in Ischemic Stroke: An UpdateAylin Baskin, Franz Buchegger, Yann Seimbille, et al.
The Oncologist|July 1, 2008
Radiolabeled and native antibodies and the prospect of cure of follicular lymphomaFranz Buchegger, Oliver W Press, Angelika Bischof Delaloye, et al.
Bulletin Du Cancer|September 20, 2007
[Radioimmunotherapy of follicular lymphoma: a step towards cure?]Nicolas Ketterer, Angelika Bischof Delaloye, Claudine Helg, et al.
Pageof 5